Source:http://linkedlifedata.com/resource/pubmed/id/11062194
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-2-6
|
pubmed:abstractText |
A rat model was used to investigate the efficacy of two polycationic peptides, ranalexin and buforin II, in the prevention of vascular prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides. The in vitro activity of the peptides was compared with those of vancomycin and teicoplanin by MIC determination and time-kill study. Moreover, the efficacy of collagen-sealed peptide-soaked Dacron was evaluated in a rat model of graft infection. Graft infections were established in the dorsal subcutaneous tissue of 120 adult male Wistar rats. The in vivo study included a control group, one contaminated group that did not receive any antibiotic prophylaxis and four contaminated groups that received an antibiotic-soaked graft. Experiments demonstrated that the activities of buforin II and ranalexin were greater than those of vancomycin and teicoplanin. Particularly, rats with buforin II-coated Dacron grafts showed no evidence of staphylococcal infection while, for the rats with ranalexin-, vancomycin- and teicoplanin-coated Dacron grafts, the quantitative graft cultures demonstrated bacterial growth (1.9 x 10(2) +/- 0.6 x 10(2) cfu/mL, 6. 2 x 103 +/- 1.9 x 10(3) cfu/mL and 5.1 x 10(4) +/- 4.8 x 10(3) cfu/mL, respectively). The study demonstrated that the use of peptide-soaked Dacron graft can result in significant bacterial growth inhibition and indicates that these compounds may be potentially useful in prosthetic surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/buforin II,
http://linkedlifedata.com/resource/pubmed/chemical/ranalexin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
751-6
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11062194-Animals,
pubmed-meshheading:11062194-Anti-Bacterial Agents,
pubmed-meshheading:11062194-Blood Vessel Prosthesis,
pubmed-meshheading:11062194-Drug Evaluation,
pubmed-meshheading:11062194-Male,
pubmed-meshheading:11062194-Models, Animal,
pubmed-meshheading:11062194-Peptides, Cyclic,
pubmed-meshheading:11062194-Proteins,
pubmed-meshheading:11062194-Rats,
pubmed-meshheading:11062194-Rats, Wistar,
pubmed-meshheading:11062194-Staphylococcal Infections,
pubmed-meshheading:11062194-Staphylococcus epidermidis
|
pubmed:year |
2000
|
pubmed:articleTitle |
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis.
|
pubmed:affiliation |
Institute of Infectious Diseases and Public Health and Department of General Surgery, INRCA IRCCS, University of Ancona, Ancona, Italy. cmalinf@popcsi.unian.it
|
pubmed:publicationType |
Journal Article
|